Nitric oxide and chronic gut inflammation: Controversies in inflammatory bowel disease

Journal of Investigative Medicine

Volumn 50, Issue 4, 2002, Pages 272-283

  Grisham, Matthew B ^a   Pavlick, Kevin P ^a   Laroux, F Stephen ^a   Hoffman, Jason ^a   Bharwani, Sulaiman ^a   Wolf, Robert E ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Crohn's disease; Free radicals; Neutrophils; Oxidants; Superoxide

Indexed keywords

FREE RADICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; COLITIS; CROHN DISEASE; DISEASE SEVERITY; ENTERITIS; GENE EXPRESSION; IMMUNOMODULATION; IMMUNOREGULATION; MOUSE; NONHUMAN; REVIEW; TISSUE INJURY; ULCERATIVE COLITIS;

ANIMALIA;

EID: 0036306260     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2002.33281     Document Type: Review

References (116)

1. Inflammatory bowel disease: Etiology and pathogenesis
2. T cells in inflammatory bowel disease: Protective and pathogenic roles
3. Experimental models of inflammatory bowel disease
4. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease
5. Expression of nitric oxide synthase in ulcerative colitis
6. Distribution of inducible nitric oxide synthase in ulcerative colitis
7. High nitric oxide synthase activity in endothelial cells in ulcerative colitis
8. Activation of microvascular endothelial cells in active ulcerative colitis and detection of inducible nitric oxide synthase
9. Greatly increased mucosal nitric oxide in ulcerative colitis determined in situ by a novel nitric oxide-selective microelectrode
10. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease
11. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis
12. Increased nitric oxide production in collagenous and lymphocytic colitis
13. Increased nitric oxide synthesis in ulcerative colitis
14. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease
15. Confirmation of nitric oxide synthesis in active ulcerative colitis by infra-red diode laser spectroscopy
16. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation
17. Localization of inducible nitric oxide synthase mRNA in inflamed gastrointestinal mucosa by in situ reverse transcriptase-polymerase chain reaction
18. Nitric oxide: A mediator of inflammation or mucosal defence
19. Role of nitric oxide in the colon of patients with ulcerative colitis
20. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease
21. Direct determination of colonic nitric oxide level: A sensitive marker of disease activity in ulcerative colitis
22. Control of intestinal inflammation by regulatory T cells
23. + regulatory T cells
24. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
25. -/- mice: An overview
26. Interleukin-10: Biology, role in inflammation and autoimmunity
27. The role of IL12 in the regulation of Th1 and Th2 differentiation
28. + thymocytes and peripheral T cells have immune suppressive activity in vitro
29. + regulatory cells that control intestinal inflammation
30. + regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance
31. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
32. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10
33. Reciprocal IFN-γ TGF-β responses regulate the occurrence of mucosal inflammation
34. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
35. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance
36. + T cells
37. Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment
38. Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety
39. Inhibition of nitric oxide synthase as a potential therapeutic target
40. Nitric oxide synthase in circulating vs. extravasated polymorphonuclear leukocytes
41. NF-κB: Ten years after
42. Redox regulation of NF-κB activation
43. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1
44. Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis
45. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice
46. Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase
47. Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats
48. Effects of nitric oxide synthase inhibition or sulfasalazine on the spontaneous colitis observed in HLA-B27 transgenic rats
49. Prolonged colonic epithelial hyporesponsiveness after colitis: Role of inducible nitric oxide synthase
50. Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis
51. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis
52. High expression of inducible nitric oxide synthase correlates with intestinal inflammation of interleukin-2-deficient mice
53. The selective beneficial effects of nitric oxide inhibition in experimental colitis
54. Role of inducible nitric oxide synthase in the regulation of VCAM-1 expression in gut inflammation
55. Role of nitric oxide in inflammation-induced suppression of secretion in a mouse model of acute colitis
56. Temporal distribution of neuronal and inducible nitric oxide synthase and nitrotyrosine during colitis in rats
57. Amelioration of chronic ileitis by nitric oxide synthase inhibition
58. Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis
59. Nitric oxide: III - A molecular prelude to intestinal inflammation
60. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity
61. Interferon-γ (IFN-γ) and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice
62. Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats
63. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity
64. Potential role of nitric oxide in a model of chronic colitis in rhesus macaques
65. The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey
66. Role of inducible nitric oxide synthase (iNOS) and peroxynitrite in gut inflammation
67. Induction of nitric oxide synthase and concomitant suppression of superoxide dismutases in experimental colitis in rats
68. Pathophysiological role of nitric oxide in rat experimental colitis
69. Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats
70. Failure of L-NAME to cause inhibition of nitric oxide synthesis: Role of inducible nitric oxide synthase
71. Nitric oxide: The Jekyll and Hyde of gut inflammation
72. Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase
73. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease
74. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis
75. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: Relevance to ischemic heart disease
76. Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
77. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells
78. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells
79. Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB
80. Inducible nitric oxide: An autoregulatory feedback inhibitor of vascular inflammation
81. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IκBα
82. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants
83. Assessing induction of IκB by nitric oxide
84. Oral administration of inducible nitric oxide synthase inhibitors reduces nitric oxide synthesis but has no effect on the severity of experimental colitis
85. Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production
86. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine
87. N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats
88. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis
89. Role of inducible nitric oxide synthase in dextran sulphate sodium-induced colitis
90. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-α
91. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
92. Nitric oxide synthase inhibitors attenuate transforming-growth-factor-β 1-stimulated capillary organization in vitro
93. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: Divergent roles of superoxide and nitric oxide
94. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation
95. Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice
96. A comparative analysis of two models of colitis in rats
97. The role of nitric oxide in inflammation and immunity
98. Nitric oxide and inflammatory joint diseases
99. An essential role for free radicals and derived species in signal transduction
100. Nitric oxide: I - Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation
101. Lack of tyrosine nitration by peroxynitrite generated at physiological pH
102. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide
103. Effects of superoxide on nitric oxide-dependent N-nitrosation reactions
104. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates: Chemical aspects involved in the balance between oxidative and nitrosative stress
105. The oxidative and nitrosative chemistry of the nitric oxide/superoxide reaction in the presence of bicarbonate
106. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly
107. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
108. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid: A novel mechanism for nitric oxide-mediated protein modification
109. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite: A potential additional mechanism of nitric oxide-dependent toxicity
110. Myoglobin-catalyzed tyrosine nitration: No need for peroxynitrite
111. Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice
112. Inducible nitric oxide synthase attenuates chronic colitis in human histocompatibility antigen HLA-B27/human β2 microglobulin transgenic rats
113. Differing effects of two nitric oxide synthase inhibitors on experimental colitis
114. Inhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB-colitis
115. Enhanced expression of iNOS in inflamed colons of IL-2-deficient mice does not impair colonic epithelial barrier function
116. Role of nitric oxide synthase inhibitor in experimental colitis induced by 2,4,6-trinitrobenzene sulphonic acid in rats